Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 6/20 | 0.46 |
| ▸ | CNR1 | P21554 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5480007 | 0.98 | ABCB1 (0.53) | ABCB1TP53LMNAKDM4EALDH1A1 | |
| SCHEMBL2047875 | 0.91 | TP53 (0.55) | ABCB1TP53LMNAKDM4EALDH1A1 | |
| SCHEMBL19072578 | 0.87 | ABCB1 (0.68) | ABCB1TP53LMNAKDM4EALDH1A1 | |
| SCHEMBL7531576 | 0.81 | HDAC4 (0.50) | ABCB1LMNAKDM4EALDH1A1HPGD | |
| SCHEMBL6004412 | 0.81 | HDAC4 (0.50) | ABCB1LMNAKDM4EALDH1A1HPGD | |
| SCHEMBL28204910 | 0.81 | ABCB1 (0.60) | ABCB1CA1CA2MEN1KMT2A | |
| SCHEMBL8784420 | 0.79 | ABCB1 (0.55) | ABCB1TP53KDM4EALDH1A1MAPT | |
| SCHEMBL3169205 | 0.79 | HDAC4 (0.52) | LMNAALDH1A1HPGDALOX15HSD17B10 | |
| SCHEMBL2095733 | 0.79 | HTR1A (0.50) | ESR1ESR2HDAC4HDAC2HDAC8 | |
| SCHEMBL3681666 | 0.79 | ESR1 (0.44) | ABCB1LMNAKDM4EALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7468464-B2 | Resorcinol derivatives for skin | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2008-12-23 | — | — | US | claimed |
| US-20080131382-A1 | Novel Resorcinol Derivatives for Skin | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2008-06-05 | — | — | US | claimed |
| CN-101184722-B | Novel resorcinol derivatives for skin | UNILEVER NV | 2011-06-22 | — | — | CN | disclosed |
| US-7468464-B2 | Resorcinol derivatives for skin | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2008-12-23 | — | — | US | disclosed |
| EP-1861353-B1 | NOVEL RESORCINOL DERIVATIVES FOR SKIN | UNILEVER PLC (GB) | 2008-10-08 | — | — | EP | disclosed |
| US-20080131382-A1 | Novel Resorcinol Derivatives for Skin | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2008-06-05 | — | — | US | disclosed |
| CN-101184722-A | Novel resorcinol derivatives for skin | UNILEVER HOME & PERSONAL CARE (NL) | 2008-05-21 | — | — | CN | disclosed |
| CN-101175711-A | Novel resorcinol derivatives | UNILEVER PLC (NL) | 2008-05-07 | — | — | CN | disclosed |
| EP-1861353-A1 | NOVEL RESORCINOL DERIVATIVES FOR SKIN | UNILEVER PLC (GB) | 2007-12-05 | — | — | EP | disclosed |
| EP-1858835-A1 | NOVEL RESORCINOL DERIVATIVES | UNILEVER PLC (GB) | 2007-11-28 | — | — | EP | disclosed |
| US-20060210498-A1 | Novel resorcinol derivatives for skin | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2006-09-21 | — | — | US | disclosed |
| WO-2006097224-A1 | NOVEL RESORCINOL DERIVATIVES FOR SKIN | UNILEVER PLC (GB) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006097223-A1 | NOVEL RESORCINOL DERIVATIVES | UNILEVER PLC (GB) | 2006-09-21 | — | — | WO | disclosed |
| US-20060210497-A1 | Novel resorcinol derivatives | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080131382-A1 | Novel Resorcinol Derivatives for Skin | NR1H2, CYP1B1, NR0B1 | ABCB1 1973/4885TP53 4288/4885LMNA 888/4885 |
| US-20060210498-A1 | Novel resorcinol derivatives for skin | NR1H2, CYP1B1, NR0B1 | ABCB1 1973/4885TP53 4288/4885LMNA 888/4885 |
| US-20060210497-A1 | Novel resorcinol derivatives | NR1H2, DEGS1, NR1H3 | ABCB1 2025/4885TP53 4391/4885LMNA 510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.